|
|
|
|
| Accelerated Yield Optimization Of Affinity Capture | Poster | SK pharmteco | High‑throughput affinity screening shows how buffer and pH optimization can boost AAV5 recovery, enabling faster, more reliable downstream process development for challenging serotypes. |
|
|
|
|
By Jeffrey S. Buguliskis, Ph.D., Deputy chief editor, Outsourced Pharma | From impurity control to technology transfer governance, these practical lessons will help sponsors navigate the realities of oligonucleotide manufacturing scale-up. | |
|
|
Navigating The New EMA Guideline For Synthetic Peptides | By Tim Sandle, Ph.D. | The European Medicines Agency’s Guideline on the Development and Manufacture of Synthetic Peptides, adopted in Dec. 2025 and effective from June 1, 2026, is an important regulatory development for peptide manufacturers. |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
